Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEFDINIR vs CEFOXITIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEFDINIR vs CEFOXITIN: Safety Overview

Metric CEFDINIR CEFOXITIN
Total FAERS Reports 1,627 750
Deaths Reported 35 48
Death Rate 2.2% 6.4%
Hospitalizations 262 252
Average Patient Age 37.8 yrs 50.8 yrs
% Female Patients 65.6% 57.6%
FDA Approval Date Apr 6, 2007 Approved Prior to Jan 1, 1982
Manufacturer Sandoz Inc B. Braun Medical Inc.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Discontinued